These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 754401)

  • 1. Prevalence of gallstones in hyperlipidemia and incidence during treatment with clofibrate and/or cholestyramine.
    Palmer RH
    Trans Assoc Am Physicians; 1978; 91():424-32. PubMed ID: 754401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM; Mok HY
    J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

  • 4. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clofibrate in primary biliary cirrhosis hypercholesterolemia and gallstones.
    Summerfield JA; Elias E; Sherlock S
    Gastroenterology; 1975 Oct; 69(4):998-1000. PubMed ID: 1175893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallstone formation in guinea pigs under different dietary conditions. Effect of vitamin C on bile acid pattern.
    Bergman F; Curstedt T; Eriksson H; van der Linden W; Sjövall J
    Med Biol; 1981 Apr; 59(2):92-8. PubMed ID: 7311630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iatrogenic cholelithiasis].
    Dederer IuM; Krylova NP; Ustinov GG
    Klin Med (Mosk); 1982; 60(8):11-5. PubMed ID: 6815377
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypolipidemic agents and gallstones.
    Med Lett Drugs Ther; 1977 Jun; 19(11):46. PubMed ID: 865410
    [No Abstract]   [Full Text] [Related]  

  • 10. The drug treatment of hyperlipidemia.
    Jones RJ
    Adv Exp Med Biol; 1977; 82():656-60. PubMed ID: 920423
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions and side effects of hypolipidemic drugs.
    Schwandt P
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):351-6. PubMed ID: 489202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment of hyperlipidemia.
    Berkowitz D
    Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug treatment of hyperlipoproteinemias].
    Hanefeld M
    Z Gesamte Inn Med; 1977 May; 32(9):139-43. PubMed ID: 906593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidemia: to treat or not to treat.
    Parsons WB
    Ariz Med; 1975 Apr; 32(4):323-8. PubMed ID: 1119953
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bile lipid composition in high-risk lithogenous patients].
    Di Cicco M; Ferraris R; Spampinato L; De La Pierre M
    Minerva Dietol Gastroenterol; 1979; 25(2):193-6. PubMed ID: 471300
    [No Abstract]   [Full Text] [Related]  

  • 20. Does cholestyramine interfere with cyclosporine absorption? A prospective study in renal transplant patients.
    Jensen RA; Lal SM; Diaz-Arias A; James-Kracke M; Van Stone JC; Ross G
    ASAIO J; 1995; 41(3):M704-6. PubMed ID: 8573896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.